Electrochemotherapy for the treatment of primary basal cell carcinoma; A randomised control trial comparing electrochemotherapy and surgery with five year follow up

European Journal of Surgical Oncology

Volumn 46, Issue 5, 2020, Pages 847-854

  Clover, A J P ^a,b   Salwa, S P ^a   Bourke, M G ^a   McKiernan, J ^a   Forde, P F ^a   O'Sullivan, S T ^b   Kelly, E J ^b   Soden, D M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b Department of Medicine National University of Ireland Cork   (Ireland)

Author keywords

Basal cell carcinoma; Electrochemotherapy; Randomised control trial; Surgery

Indexed keywords

BLEOMYCIN; ANTINEOPLASTIC ANTIBIOTIC;

ADULT; AGED; BASAL CELL CARCINOMA; CANCER RECURRENCE; CANCER SURGERY; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; ELECTROCHEMOTHERAPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; EPIDEMIOLOGY; LONGITUDINAL STUDY; PATHOLOGY; PROCEDURES; REOPERATION; RETREATMENT; SKIN SURGERY; SKIN TUMOR; SURGICAL MARGIN; TUMOR RECURRENCE; TUMOR VOLUME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CARCINOMA, BASAL CELL; DERMATOLOGIC SURGICAL PROCEDURES; ELECTROCHEMOTHERAPY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MARGINS OF EXCISION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REOPERATION; RETREATMENT; SKIN NEOPLASMS; TUMOR BURDEN; YOUNG ADULT;

EID: 85076841054     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2019.11.509     Document Type: Conference Paper

References (34)

1. Mir, L.M., et al. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 27:1 (1991), 68–72.
2. Belehradek, J. Jr., et al. Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer 27:1 (1991), 73–76.
3. Belehradek, M., et al. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 72:12 (1993), 3694–3700.
4. Bourke, M.G., et al. Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: ten-year audit of single centre experience. Breast Canc Res Treat 161:2 (2017), 289–297.
5. Sadadcharam, M., Soden, D.M., O'Sullivan G, C., Electrochemotherapy: an emerging cancer treatment. Int J Hyperth 24:3 (2008), 263–273.
6. Mali, B., et al. Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol 39:1 (2013), 4–16.
7. Gehl, J., et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases., 57(7), 2018, 874–882.
8. Spratt, D.E., et al. Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis. J Clin Oncol 32:28 (2014), 3144–3155.
9. Glass, L.F., et al. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Dermatol 37:4 (1997), 596–599.
10. National Institute for Health and Care Excellence (NICE), Guidance. Electro-chemotherapy for metastases in the skin from tumours of non-skin origin and melanoma. Available at: https://www.nice.org.uk/guidance/ipg446. (Accessed 2 February 2017)
11. Salwa, S.P., et al. Electrochemotherapy for the treatment of ocular basal cell carcinoma; a novel adjunct in the disease management. J Plast Reconstr Aesthet Surg 67:3 (2014), 403–406.
12. Campana, L.G., et al. Basal cell carcinoma: 10-year experience with electrochemotherapy. J Transl Med, 15(1), 2017, 122.
13. Flight, L., Julious, S.A., Practical guide to sample size calculations: non-inferiority and equivalence trials. Pharm Stat 15:1 (2016), 80–89.
14. Campana, L.G., et al. Recommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review. Radiol Oncol 50:1 (2016), 1–13.
15. Trakatelli, M., et al. Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol 24:3 (2014), 312–329.
16. Telfer, N.R., Colver, G.B., Morton, C.A., Guidelines for the management of basal cell carcinoma. Br J Dermatol 159:1 (2008), 35–48.
17. Marty, M., et al. Electrochemotherapy - an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl 4:11 (2006), 3–13.
18. Orlowski, S., et al. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 37:24 (1988), 4727–4733.
19. Griffiths, R.W., Suvarna, S.K., Stone, J., Do basal cell carcinomas recur after complete conventional surgical excision?. Br J Plast Surg 58:6 (2005), 795–805.
20. Smith, V., Walton, S., Treatment of facial Basal cell carcinoma: a review. J Skin Cancer, 2011, 2011, 380371.
21. Peycheva, E., Daskalov, I., Electrochemotherapy of skin tumours: comparison of two electroporation protocols. J buon 9:1 (2004), 47–50.
22. Bertino, G., et al. European research on electrochemotherapy in head and neck cancer (EURECA) project: results of the treatment of skin cancer. Eur J Cancer 63 (2016), 41–52.
23. Gehl, J., Skovsgaard, T., Mir, L.M., Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anti Cancer Drugs 9:4 (1998), 319–325.
24. De Silva, S.P., Dellon, A.L., Recurrence rate of positive margin basal cell carcinoma: results of a five-year prospective study. J Surg Oncol 28:1 (1985), 72–74.
25. Gurunluoglu, R., et al. No residual basal cell carcinoma after excision for biopsy-proven tumor: clinical and medicolegal implications. Plast Reconstr Surg Glob Open, 1(9), 2013, e87.
26. O'Brien, M.A., et al. Local tumour ablative therapies: opportunities for maximising immune engagement and activation. Biochim Biophys Acta 1846:2 (2014), 510–523.
27. Swetter, S.M., et al. Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinomas: rate of tumor regression in excisional specimens. J Cutan Pathol 30:2 (2003), 139–146.
28. Falk, H., et al. Electrochemotherapy and calcium electroporation inducing a systemic immune response with local and distant remission of tumors in a patient with malignant melanoma - a case report., 56(8), 2017, 1126–1131.
29. Avril, M.F., et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Canc 76:1 (1997), 100–106.
30. Hall, V.L., et al. Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol 37:1 (1986), 33–34.
31. Rowe, D.E., Carroll, R.J., Day, C.L. Jr., Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 15:3 (1989), 315–328.
32. Rhodes, L.E., et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 140:1 (2004), 17–23.
33. Falk, H., et al. Calcium electroporation for treatment of cutaneous metastases; a randomized double-blinded phase II study, comparing the effect of calcium electroporation with electrochemotherapy., 57(3), 2018, 311–319.
34. Kis, E., et al. Successful treatment of multiple basaliomas with bleomycin-based electrochemotherapy: a case series of three patients with Gorlin-Goltz syndrome. Acta Derm Venereol 92:6 (2012), 648–651.